home / stock / cmrx / cmrx articles

CMRX Articles, Chimerix Inc.

Stock Information
Company Name: Chimerix Inc.
Stock Symbol: CMRX
Market: NASDAQ
Website: chimerix.com
Menu
CMRX CMRX Quote CMRX Short CMRX News CMRX Articles CMRX Message Board
Get CMRX Alerts

News, Short Squeeze, Breakout and More Instantly...
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference | Benzinga

DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that...
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024 | Benzinga

DURHAM, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that...

Chimerix Appoints Marc D. Kozin to Board of Directors | Benzinga

DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that ...

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update | Benzinga

– ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 – – Phase 2 ONC201 Data Publis...
Chimerix to Present at TD Cowen 44th Annual Health Care Conference | Benzinga

DURHAM, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that ...

Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024 | Benzinga

DURHAM, N.C., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that ...

Chimerix Appoints Lisa Decker to Board of Directors | Benzinga

DURHAM, N.C., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that m...
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer | Benzinga

DURHAM, N.C., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that m...

COO and CCO at Chimerix Acquires Company Stock Options Worth 800,000 Shares | Benzinga

Thomas Riga, COO and CCO at Chimerix (NASDAQ:CMRX), reported a large acquisition of company stock options on November 16, according to a new SEC fi...

Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer | Benzinga

DURHAM, N.C., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that m...
Next 10